EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

LRIG2 suppresses NK cell-induced GSDME-mediated pyroptosis via the LAMP1-STAT3 pathway in glioma

Xiaoshuang Hou, Lan Lin, Po Zhang, Youwei Li, Minhai Dong, Sui Chen, Xiaohu Oyang, Jingbo Wang, Fangling Cheng, Xiaopeng Li, Min Zhao, Feng Mao und 4 weitere

Journal for ImmunoTherapy of Cancer · 2026

DOI: 10.1136/jitc-2026-015730 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2026. Verfasst von Xiaoshuang Hou und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Killer Cells, Natural, Pyroptosis, STAT3 Transcription Factor, Glioma. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gliomas are resistant to current therapies, and natural killer (NK) cell-based immunotherapy shows limited efficacy. Gasdermin E (GSDME)-mediated pyroptosis contributes to NK-induced tumor killing, but NK cell dysfunction in the glioma microenvironment remains poorly understood. This study investigates whether leucine-rich repeats and immunoglobulin-like domains 2 (LRIG2) enable glioma cells to evade NK-induced pyroptosis and elucidates the underlying mechanism.

Methods

We used in vitro co-culture systems with glioma cell lines (LN229, HS683, FU) and primary NK cells or NK92-MI cells to assess cytotoxicity, pyroptosis (lactate dehydrogenase release, morphology, GSDME cleavage by western blot), and cytokine release (Cytometric Bead Array). In vivo, orthotopic glioma models in C57BL/6 and RAG1-KO mice received intracranial stimulator of interferon genes agonist diABZI. Mechanistic dissection involved biochemical approaches (co-immunoprecipitation-mass spectrometry and membrane protein extraction), cellular imaging (immunofluorescence), and genetic perturbation via CRISPR-mediated knockdown.

Results

NK cells induced GSDME-dependent pyroptosis in glioma cells in vitro, but this was impaired in vivo due to suppressed NK cytotoxicity. LRIG2 was highly expressed in gliomas; its overexpression inhibited GSDME cleavage, pyroptosis, and glioma cell death, whereas LRIG2 knockdown enhanced these effects. Mechanistically, soluble LRIG2 shed from glioma cells bound to lysosomal-associated membrane protein 1 (LAMP1) on NK cells, upregulating phosphorylated-signal transducer and activator of transcription (p-STAT3) via Janus kinase 1 (JAK1) and reducing granzyme B and perforin release. Disrupting the LRIG2–LAMP1–STAT3 axis by LRIG2 knockdown or STAT3 knockout restored NK cytotoxicity and GSDME cleavage. Combining LRIG2 knockdown with diABZI significantly enhanced NK granzyme B expression and prolonged mouse survival.

Conclusions

LRIG2 enables glioma immune evasion by suppressing NK-induced GSDME-mediated pyroptosis via the LAMP1–STAT3 pathway. Targeting this axis represents a promising strategy to enhance NK cell-based immunotherapy for gliomas, positioning LRIG2 as a potential biomarker and therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalPyroptosisSTAT3 Transcription FactorGliomaLysosomal-Associated Membrane Protein 1Lysosomal Membrane ProteinsAnimalsMiceHumansGasderminsSignal TransductionMice, Inbred C57BLCell Line, TumorCoculture Techniques

Stichwörter der Autor:innen

Central Nervous System CancerImmunosuppressionNatural killer - NK

Substanzen

STAT3 Transcription FactorGasderminsLysosomal-Associated Membrane Protein 1GSDME protein, humanLysosomal Membrane ProteinsSTAT3 protein, humanGsdme protein, mouseLamp1 protein, mouse

Autor:innen und Institutionen

  • Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • State Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology,Chinese Academy of Sciences, Wuhan, China.
  • Department of Neurosurgery, Union Hospital, Wuhan, China.
  • Department of Pain Management, Southeast University, Nanjing, China.
  • Department of Neurosurgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Wuhan, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Hou, X., Lin, L., Zhang, P., Li, Y., Dong, M., Chen, S., Oyang, X., Wang, J., Cheng, F., Li, X., Zhao, M., Mao, F., Yu, X., Hu, D., Wang, B., & Guo, D. (2026). LRIG2 suppresses NK cell-induced GSDME-mediated pyroptosis via the LAMP1-STAT3 pathway in glioma. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2026-015730

Vancouver

Hou X, Lin L, Zhang P, Li Y, Dong M, Chen S, et al. LRIG2 suppresses NK cell-induced GSDME-mediated pyroptosis via the LAMP1-STAT3 pathway in glioma. Journal for ImmunoTherapy of Cancer. 2026. doi:10.1136/jitc-2026-015730

BibTeX
@article{Hou2026,
  author = {Hou, Xiaoshuang and Lin, Lan and Zhang, Po and Li, Youwei and Dong, Minhai and Chen, Sui and Oyang, Xiaohu and Wang, Jingbo and Cheng, Fangling and Li, Xiaopeng and Zhao, Min and Mao, Feng and Yu, Xingjiang and Hu, Desheng and Wang, Baofeng and Guo, Dongsheng},
  title = {LRIG2 suppresses NK cell-induced GSDME-mediated pyroptosis via the LAMP1-STAT3 pathway in glioma},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  doi = {10.1136/jitc-2026-015730}
}
Kostenlos starten →